The DOI matches its Crossref record; 36 of the 49 references it cites were found in a registry or an index.
Predicting Phenotype in Steroid 21-Hydroxylase Deficiency? Comprehensive Genotyping in 155 Unrelated, Well Defined Patients from Southern Germany
Abstract
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders. CAH is most often caused by deficiency of steroid 21-hydroxylase. The frequency of CYP21-inactivating mutations and the genotype-phenotype relationship were characterized in 155 well defined unrelated CAH patients. We were able to elucidate 306 of 310 disease-causing alleles (diagnostic sensitivity, 98.7%). The most frequent mutation was the intron 2 splice site mutation (30.3%), followed by gene deletions (20.3%), the I172N mutation (19.7%) and large gene conversions (7.1%). Five point mutations were detected that have not been described in other CAH cohorts. Genotypes were categorized in 4 mutation groups (null, A, B, and C) according to their predicted functional consequences and compared to the clinical phenotype. The positive predictive value for null mutations (ppvnull) was 100%, as all patients with these mutations had a salt-wasting phenotype. In mutation group A (intron 2 splice site mutation in homozygous or heterozygous form with a null mutation), the ppvA to manifest with salt-wasting CAH was 90%. In group B predicted to result in simple virilizing CAH (I172N in homozygous or compound heterozygous form with a more severe mutation), ppvB was 74%. In group C (P30L, V281L, P453S in homozygous or compound heterozygous form with a more severe mutation), ppvC was 64.7% to exhibit the nonclassical form of CAH, but 90% when excluding the P30L mutation. Thus, in general, a good genotype-phenotype relationship is shown in patients with either the severest or the mildest mutations. A considerable degree of divergence is observed within mutation groups of intermediate severity. As yet undefined factors modifying 21-hydroxylase gene expression and steroid hormone action are likely to account for these differences in phenotypic expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In European and North American population, where long-standing newborn screening programs facilitate early detection, large gene deletions and CYP21A1P/CYP21A2 chimeric conversions, predominantly associated with SW phenotypes, constitute 20-30% of pathogenic alleles (25, 28, 30, 31).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [25]
In the citing paper
“Importantly, genotype-phenotype discordance in CAH reflects not only the primary CYP21A2 pathogenic variant but also allelic configuration (cis/trans), promoter strength, splicing efficiency, copy number variation, and extra-adrenal metabolism.”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [25]
In the citing paper
“Deletions, the splice site mutation in intron 2 (c.293-13A/C>G) and p.Ile172Asn (I172N) are the most common mutations in most populations (189,195-213).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [199]
In the citing paper
“Thus, approximately 75-80% of cases of 21-hydroxylase deficiency derive from micro-or macrogene conversion events where some or all of the CYP21A1P pseudogene replaces the corresponding area of the CYP21A2 gene, thus reduc-ing the expression of the encoded P450c21 protein and/or impairing its activity (352, 381).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [381]
In the citing paper
“A careful study of 155 German patients confirmed these results, finding gene deletions in 20.3%, large gene conversions in 7.1%, microconversions in 71.3% (intron 2 mutation in 30.3%;I172N in 19.7%), and uncharacterized mutations in 1.3% (381).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [381]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Structure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
White, P. C., Grossberger, D., Onufer, B. J., Chaplin, D. D., New, M. I., Dupont, B., & Strominger, J. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1089 · Cited by 490
Kuivaniemi, H., Tromp, G., & Prockop, D. J. (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)9:4 · Cited by 371
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Steroid 21-hydroxylase deficiency: genotype may not predict phenotype
Wilson, R. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.8.2322 · Cited by 324
Research works printed but not linked: 1
- Donohoue, 1995, 7, 2929
Cited by
Sorted by citations
Items 101–200 of 395
Zimmermann, A., Grigorescu‐Sido, P., Alkhzouz, C., Patberg, K., Bucerzan, S., Schulze, E., Zimmermann, T., Rossmann, H., Geiss, H. C., Lackner, K. J., et al. (2010) · Hormone Research in Paediatrics · doi:10.1159/000313368 · Cited by 38
Pregnancy in Congenital Adrenal Hyperplasia
Reisch, N. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.011 · Cited by 37
Welzel, M., Wüstemann, N., Ŝimić-Schleicher, G., Dörr, H. G., Schulze, E., Shaikh, G., Clayton, P., Grötzinger, J., Holterhus, P., & Riepe, F. G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1874 · Cited by 36
Olney, R. C., Mougey, E. B., Wang, J., Shulman, D. I., & Sylvester, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8273 · Cited by 36
Functional studies of two novel and two rare mutations in the 21-hydroxylase gene
Barbaro, M., Baldazzi, L., Balsamo, A., Lajić, S., Robins, T., Barp, L., Pirazzoli, P., CACCIARI, E., Cicognani, A., & Wedell, A. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0043-7 · Cited by 35
Dumic, K. K., Grubić, Z., Yuen, T., Wilson, R. C., Kuŝec, V., Barišić, I., Štingl, K., Sansović, I., Škrabić, V., Dumić, M., et al. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.035 · Cited by 34
Gangodkar, P. V., Khadilkar, V. V., Raghupathy, P., Kumar, R., Dayal, A. A., Dayal, D., Ayyavoo, A., Godbole, T., Jahagirdar, R. R., Bhat, K., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02494-z · Cited by 33
Schreiner, F., Brack, C., Salzgeber, K., Vorhoff, W., Woelfle, J., & Gohlke, B. C. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0505-0 · Cited by 35
Grischuk, Y., Rubtsov, P., Riepe, F. G., Grötzinger, J., Beljelarskaia, S., Prassolov, V., Kalintchenko, N., Semitcheva, T., Peterkova, V., Tiulpakov, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0777 · Cited by 33
Self-citationAuer, M. K., Paizoni, L., Hofbauer, L. C., Rauner, M., Chen, Y., Schmidt, H., Huebner, A., Bidlingmaier, M., & Reisch, N. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105734 · Cited by 33
Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
Ammini, A., Marumudi, E., Sharma, A., Kulshreshtha, B., Khadgawat, R., & Khurana, M. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.95679 · Cited by 33
Janner, M., Pandey, A. V., Mullis, P. E., & Flück, C. E. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02172 · Cited by 33
Grigorescu-Sido, A., Weber, M. M., Sido, P. G., Clausmeyer, S., Heinrich, U., & Schulze, E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0379 · Cited by 33
Molecular Diagnosis of CYP21 Mutations in Congenital Adrenal Hyperplasia
Speiser, P. (2001) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200101020-00003 · Cited by 33
Chan, A. O. K., But, W. M., Ng, K. L., Wong, L. M., Lam, Y. Y., Tiu, S. C., Lee, K. F., Lee, C. Y., Loung, P. Y., Berry, I. R., et al. (2011) · Steroids · doi:10.1016/j.steroids.2011.04.010 · Cited by 32
Forest, M. G., Tardy, V., Nicolino, M. P., David, M., & Morel, Y. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81754-8 · Cited by 32
Minutolo, C., Nadra, A. D., Fernández, C. S., Taboas, M., Buzzalino, N. D., Casali, B., Belli, S., Charreau, E. H., Alba, L. G., & Daín, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015899 · Cited by 33
Mooij, C. F., Webb, E. A., der Grinten, H. L. C., & Krone, N. P. (2016) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-311910 · Cited by 31
Self-citationBarbaro, M., Soardi, F. C., Östberg, L. J., Persson, B., de Mello, M. P., Wedell, A., & Lajić, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12526 · Cited by 31
Congenital Adrenal Hyperplasia: The Molecular Basis of 21-Hydroxylase Deficiency in H-2aw18 Mice
Riepe, F. G., Tatzel, S., Sippell, W. G., Pleiss, J., & Krone, N. P. (2005) · Endocrinology · doi:10.1210/en.2004-1563 · Cited by 31
Self-citationMutation Analysis of the CYP21A2 Gene in the Iranian Population
Rabbani, B., Mahdieh, N., Ashtıani, M. T. H., Larijani, B. A., Akbari, M. T., New, M. I., Parsa, A. A., Schouten, J. P., & Rabbani, A. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0099 · Cited by 30
Xu, C., Jia, W., Cheng, X., Ying, H., Chen, J., Xu, J., Guan, Q., Zhou, X., Zheng, D., Li, G., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.671 · Cited by 29
Update: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 595 Pregnancies
New, M. I., Carlson, A. D., Obeid, J. S., Marshall, I. H., Cabrera, M. S., Goseco, A., Lin‐Su, K., Putnam, A. S., Wei, J., & Wilson, R. C. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000081685.21823.46 · Cited by 29
Sadeghi, F., Yurur-Kutlay, N., Berberoğlu, M., Çetinkaya, E., Aycan, Z., Kara, C., Ruhi, H. I., Öçal, G., Şıklar, Z., Elhan, A. H., et al. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.8.781 · Cited by 28
Zhang, B., Lü, L., & Lu, Z. (2017) · Journal of International Medical Research · doi:10.1177/0300060516685204 · Cited by 29
Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points
Eshragh, N., Doan, L. V., Connelly, K. J., Denniston, S., Willis, S., & LAFRANCHI, S. H. (2020) · Hormone Research in Paediatrics · doi:10.1159/000508075 · Cited by 28
Milacic, I., Barac, M., Milenković, T., Ugrin, M., Klaassen, K., Skakić, A., Jesic, M., Joksić, I., Mitrović, K., Todorovic, S., et al. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0366-8 · Cited by 27
Challenges in the diagnosis and management of disorders of sex development
KUTNEY, K. A., Konczal, L. L., Kaminski, B. A., & Uli, N. K. (2016) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21147 · Cited by 27
Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia
Guarnotta, V., Niceta, M., Bono, M., Marchese, S., Fabiano, C., Indelicato, S., Gaudio, F. D., Garofalo, P., & Giordano, C. S. D. S. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105554 · Cited by 28
Turan, I., Tastan, M., Boga, D. D., Gurbuz, F., Kotan, L. D., Tuli, A., & Yüksel, B. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.103782 · Cited by 25
Nguyen, H.-H., Hannemann, F., Hartmann, M. F., Małunowicz, E., Wudy, S. A., & Bernhardt, R. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.04.016 · Cited by 25
Molecular Defects of the CYP21A2 Gene in Greek-Cypriot Patients with Congenital Adrenal Hyperplasia
Skordis, N., Kyriakou, A., Tardy, V., Ioannou, Y. S., Varvaresou, A., Dracopoulou, M., Patsalis, P. C., Shammas, C., Neocleous, V., & Phylactou, L. A. (2010) · Hormone Research in Paediatrics · doi:10.1159/000320040 · Cited by 25
CYP21 mutations in simple virilizing congenital adrenal hyperplasia
Lajić, S., Robins, T., Krone, N. P., Schwarz, H. P., & Wedell, A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100261 · Cited by 26
Self-citationKocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Yau, M., Khattab, A., & New, M. I. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.001 · Cited by 24
Mineralocorticoid Deficiency and Treatment in Congenital Adrenal Hyperplasia
Padidela, R., & Hindmarsh, P. C. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/656925 · Cited by 36
Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations
Skordis, N., Neocleous, V., Shammas, C., Phedonos, A., & Phylactou, L. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.145077 · Cited by 25
Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
New, M. I., Lekarev, O., Mancenido, D., Parsa, A. A., & Yuen, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00003-x · Cited by 24
Carvalho, B., Marques, C. J., Silva, R. S., Fontoura, M., Carvalho, D. M., & Carvalho, F. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1108-1419 · Cited by 25
Substitution therapy in adult patients with congenital adrenal hyperplasia
Reisch, N. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.11.002 · Cited by 23
Welzel, M., Schwarz, H., Hedderich, J., Dörr, H. G., Binder, G., Brämswig, J., Krude, H., Richter-Unruh, A., Niedziela, M., Gromoll, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1338 · Cited by 23
Self-citationof Some New Heterocyclic Schiff Bases Derived from Thiocarbohydrazide
El‐mahdy, K. M., El‐Kazak, A. M., Abdel‐Megid, M., Seada, M., & Farouk, O. (2016) · Acta chimica slovenica · doi:10.17344/acsi.2015.1555 · Cited by 23
Robins, T., Barbaro, M., Lajić, S., & Wedell, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1937 · Cited by 23
Sertedaki, A., Papadimitriou, A., Voutetakis, A., Dracopoulou, M., Maniati-Christidi, M., & Dacou‐Voutetakis, C. (2002) · Pediatric Research · doi:10.1203/00006450-200212000-00020 · Cited by 24
Future Directions for Adrenal Insufficiency: Cellular Transplantation and Genetic Therapies
Graves, L. E., Torpy, D. J., Coates, P. T., Alexander, I. E., Bornstein, S. R., & Clarke, B. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac751 · Cited by 23
Skordis, N., Shammas, C., Efstathiou, E., Kaffe, K., Neocleous, V., & Phylactou, L. A. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.05.013 · Cited by 23
Giwercman, Y. L., Nordenskjöld, A., Ritzén, E. M., Nilsson, K. O., Ivarsson, S. A., Grandell, U., & Wedell, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8518 · Cited by 22
Auer, M. K., Paizoni, L., Neuner, M., Lottspeich, C., Schmidt, H., Bidlingmaier, M., Hawley, J. M., Keevil, B. G., & Reisch, N. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105921 · Cited by 24
Grigorescu-Sido, A., Bettendorf, M., Schulze, E., Duncea, I., & Heinrich, U. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071876 · Cited by 42
Yang, M., & White, P. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae535 · Cited by 20
Genetic aetiology of primary adrenal insufficiency in Chinese children
Chang, Z., Lu, W., Zhao, Z., Li, X., Li, X., Ye, R., Ni, J., Zhou, P., Zhang, M., Cheng, R., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01021-x · Cited by 20
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 24
Bonfig, W., & Schwarz, H. (2010) · Hormone Research in Paediatrics · doi:10.1159/000322580 · Cited by 20
Self-citationDiagnosis and management of classical congenital adrenal hyperplasia
Marumudi, E., Khadgawat, R., Surana, V., Shabir, I., Joseph, A. A., & Ammini, A. C. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.007 · Cited by 20
Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency
Luczay, A., Török, D., Ferenczi, A., Majnik, J., Sólyom, J., & Fekete, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02162 · Cited by 21
Greene, C. N., Cordovado, S. K., Turner, D. P., Keong, L. M., Shulman, D. I., & Mueller, P. W. (2014) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.07.002 · Cited by 19
Congenital Adrenal Hyperplasia
Vos, A. A., & Bruinse, H. W. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181d61046 · Cited by 18
Nigawara, T., Kageyama, K., Sakihara, S., Takayasu, S., KAWAHARA, M., Imai, A., Οhyama, C., Usui, T., Sasano, H., & Suda, T. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07-119 · Cited by 16
21-hydroxylase deficiency: From molecular genetics to clinical presentation
Trakakis, E., Laggas, D., Salamalekis, E., & Creatsas, G. C. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345366 · Cited by 19
Koppens, P. F. J., Smeets, H. J. M., de Wijs, I. J., & Degenhart, H. J. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.5.e53 · Cited by 19
Liu, S.-Y., Lee, C.-T., Tung, Y.-C., Chien, Y.-H., Hwu, W.-L., & Tsai, W.-Y. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.03.008 · Cited by 18
Shammas, C., Neocleous, V., Toumba, M., Costi, C., Phedonos, A., Efstathiou, E., Kyriakou, A., Phylactou, L. A., & Skordis, N. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0381 · Cited by 18
Zhang, H., Yang, J., Zhang, M., Zhang, W., Liu, J., Wang, W., Ning, G., & Li, X. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03356.x · Cited by 18
Guth, L. J., Witchel, R. I., Witchel, S. F., & Lee, P. A. (2006) · Journal of Gay & Lesbian Psychotherapy · doi:10.1300/j236v10n02_04 · Cited by 18
Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype
Gurgov, S., Bernabé, K. J., Stites, J., Cunniff, C. M., Lin‐Su, K., Felsen, D., New, M. I., & Poppas, D. P. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13370 · Cited by 17
Genetic defects of the CYP21A2 gene in girls with premature adrenarche
Skordis, N., Shammas, C., Phedonos, A., Kyriakou, A., Toumba, M., Neocleous, V., & Phylactou, L. A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0223-1 · Cited by 17
Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia
Prado, M. J., de Castro, S. M., Kopacek, C., de Mello, M. P., Rispoli, T., Grandi, T., da Silva, C. M. D., & Rossetti, M. L. R. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0296-6 · Cited by 17
An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency
Hannah‐Shmouni, F., & Stratakis, C. A. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9447-2 · Cited by 17
Sexual Well-Being in Adult Male Patients with Congenital Adrenal Hyperplasia
Dudzińska, B., Leubner, J., Ventz, M., & Quinkler, M. O. (2014) · International Journal of Endocrinology · doi:10.1155/2014/469289 · Cited by 17
Silva, R. S., Cardoso, R., Lopes, L., Fonseca, M., Espada, F., Sampaio, L., Brandão, C., Antunes, A. L. M. D. S., Bragança, G., Coelho, R. C. L. A., et al. (2019) · Hormone Research in Paediatrics · doi:10.1159/000497485 · Cited by 17
A Rare Duplicated 21-Hydroxylase Haplotype and ade NovoMutation: A Family Analysis
Baumgartner-Parzer, S. M., Nowotny, P., Waldhäusl, W., & Vierhapper, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021589 · Cited by 17
Kim, J. H., Kim, G.-H., Yoo, H., & Choi, J. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2346108.054 · Cited by 18
Sarafoglou, K., Lorentz, C. P., Otten, N., Oetting, W. S., & Grebe, S. K. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01694.x · Cited by 16
Neocleous, V., Fanis, P., Phylactou, L. A., & Skordis, N. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00733 · Cited by 16
Krone, N. P., Riepe, F. G., Grötzinger, J., Partsch, C., Brämswig, J., & Sippell, W. G. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0655-3 · Cited by 16
Self-citationBleicken, C., Loidi, L., Dhir, V., Parajes, S., Quinteiro, C., Dominguez, F., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · Human Mutation · doi:10.1002/humu.20926 · Cited by 15
Self-citationKıraç, D., Güney, A. İ., Akçay, T., Güran, T., Ulucan, K., Turan, S., Ergeç, D., Koç, G., Eren, F., Kaspar, E. Ç., et al. (2014) · Annals of Human Genetics · doi:10.1111/ahg.12083 · Cited by 15
Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency
Fajkusová (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000504 · Cited by 15
Dundar, A., Bayramov, R., Önal, M. G., Akkus, M., Doğan, M. E., Kenanoğlu, S., Güneş, M. C., Kazimli, U., Özbek, M. N., Ercan, O., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04809-4 · Cited by 15
Riepe, F. G., Hiort, O., Grötzinger, J., Sippell, W. G., Krone, N. P., & Holterhus, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2646 · Cited by 16
Self-citationCongenital Adrenal Hyperplasia: From Genetics and Biochemistry to Clinical Practice, Part 1
Collett‐Solberg, P. F. (2001) · Clinical Pediatrics · doi:10.1177/000992280104000101 · Cited by 14
Dörr, H.-G., Schulze, N., Bettendorf, M., Binder, G., Bonfig, W., Denzer, C., Dunstheimer, D., Salzgeber, K., Schmidt, H., Schwab, K. O., et al. (2020) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-020-00100-w · Cited by 14
Toraman, B., Ökten, A., Kalay, E., Karagüzel, G., Dinçer, T., Açıkgöz, E. G., & Karagüzel, A. (2013) · Gene · doi:10.1016/j.gene.2012.10.059 · Cited by 14
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 14
Genotype, phenotype and hormonal levels correlation in non-classical congenital adrenal hyperplasia.
Einaudi, S., Napolitano, E., Restivo, F., Motta, G., Baldi, M., Tuli, G., Grosso, E., Migone, N., Menegatti, E., & Manieri, C. (2011) · PubMed · doi:10.3275/7410 · Cited by 14
Baradaran‐Heravi, A., Vakili, R., Robins, T., Carlsson, J., Ghaemi, N., Arabi, A., & Abbaszadegan, M. R. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02886.x · Cited by 14
Esponera, C. B., Bigatá, T. G., Pérez, J., & Corripio, R. (2013) · BMJ Case Reports · doi:10.1136/bcr-2012-008281 · Cited by 14
Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia
Neocleous, V., Ioannou, Y. S., Bartsota, M., Costi, C., Skordis, N., & Phylactou, L. A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.015 · Cited by 14
Brønstad, I., Breivik, L., Methlie, P., Wolff, A. S. B., Bratland, E., Nermoen, I., Løvås, K., & Husebye, E. S. (2014) · Endocrine Connections · doi:10.1530/ec-14-0032 · Cited by 15
Variations in the 3′UTR of theCYP21A2Gene in Heterozygous Females with Hyperandrogenaemia
Neocleous, V., Fanis, P., Toumba, M., Phedonos, A., Picolos, M. K., Andreou, E., Kyriakides, T. C., Tanteles, G. A., Shammas, C., Phylactou, L. A., et al. (2017) · International Journal of Endocrinology · doi:10.1155/2017/8984365 · Cited by 14
Grunt, S., Steinlin, M., Weisstanner, C., Schöning, M., Mullis, P. E., & Flück, C. E. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348515 · Cited by 13
Xia, Y., Shi, P., Gao, S., Liu, N., Zhang, H., & Kong, X. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106156 · Cited by 14
Human Gonads Do Not Contribute to the Circulating Pool of 11-Oxygenated Androgens
Charoensri, S., Rege, J., Lee, C., Marko, X., Sherk, W. M., Sholinyan, J., Rainey, W. E., & Turcu, A. F. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae420 · Cited by 13
Kawarai, Y., Ishikawa, H., Segawa, T., Teramoto, S., Tanaka, T., & Shozu, M. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13288 · Cited by 13
21-Hydroxylase Genotyping in Australasian Patients with Congenital Adrenal Hyperplasia
Jeske, Y. W. A., McGown, I. N., Harris, M. A., Bowling, F. G., Choong, C. S., Cowley, D. M., & Cotterill, A. M. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.2.127 · Cited by 13
Lee, C., Chan, A. O.-K., Fok, J. M., Mak, M. W., Yu, K., Lee, K., & Shek, C. (2013) · Hong Kong Medical Journal · doi:10.12809/hkmj133717 · Cited by 13
Disorders of Growth and Development
Richmond, E. J., & Rogol, A. D. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-277-7_21 · Cited by 13
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
Epidemiology and Causes of Primary Adrenal Insufficiency in Children: A Population-Based Study
Borchers, J., Pukkala, ., Mäkitie, O., & Laakso, S. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad283 · Cited by 14
Lee, C.-T., Tung, Y., Hsiao, P.-H., Lee, J.-S., & Tsai, W. (2010) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(10)60035-6 · Cited by 13
Metadata
- Authors
- Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Schwarz, Hans Peter
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-03-01
- Volume
- 85
- Issue
- 3
- Pages
- 1059-1065
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2066497061
- Semantic Scholar
- a988cc456aad7cb2ff501db38740a080992699c6
- Cited by
- 397
- References
- 49
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 10 · 2023: 15 · 2022: 9 · 2021: 27 · 2020: 17 · 2019: 21 · 2018: 10 · 2017: 11 · 2016: 25 · 2015: 12 · 2014: 19 · 2013: 21 · 2012: 16
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21, genotype-phenotype correlation, CYP21 mutations, salt-wasting phenotype, compound heterozygosity, gene conversion, positive predictive value
- MeSH terms
- Adrenal Hyperplasia, Congenital, Alleles, DNA Mutational Analysis, Gene Frequency, Genotype, Germany, Humans, Mutation, Phenotype, Predictive Value of Tests, Steroid 21-Hydroxylase, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review